Case-Based Roundtable Meetings Spotlight: November 1, 2022

Clinical Commentary: Data to Consider When Sequencing Therapy in Castration-Resistant Prostate Cancer

November 15, 2022

Clinical Articles

At a live event discussing the case of a man, aged 75 years, with metastatic castration-resistant prostate cancer, Rana McKay, MD, focused on the makeup and results of the pivotal phase 4 CARD and phase 3 VISION studies.

Roundtable Discussion: The Role of Adjuvant Therapies for NSCLC Based on Disease Stage

November 14, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Joel Neal, MD, PhD, and Leah Backhus, MD, MPH, discussed adjuvant therapies including chemotherapy, immunotherapy, and targeted therapy for patients with non–small cell lung cancer.

Roundtable Discussion: Ayyappan Breaks Down New and Emerging Approaches in DLBCL

November 13, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Sabarish Ayyappan, MD, discussed with participants which therapy would be appropriate for an older patient with relapsed/refractory diffuse large B-cell lymphoma.